Restless legs syndrome/Willis–Ekbom disease. Questions and answers Review article

Main Article Content

Jarosław Sławek

Abstract

Restless legs syndrome, also known as Willis-Ekbom disease, is one of the most common sensory-motor disturbances. Symptoms consist in the compulsion to move the lower limbs caused by unspecified unpleasant sensations. This disorder is difficult to diagnose because it imitates other diseases. For this reason, differential diagnosis plays a large role in diagnosis. In the case of a slight exacerbation of symptoms, non-pharmacological activities are used, such as improving the conditions of falling asleep, avoiding intense work at the computer just before bedtime, stimulants (coffee, strong tea), energy drinks. Pharmacological treatment should be introduced if the symptoms are more severe. Pharmacotherapy depends on the nature of the symptoms. In the recurrent form, the drug of choice is the lowest effective dose of levodopa. In chronic forms, we permanently use drugs from the group of dopamine agonists (pramipexole, ropinirole, rotigotine) or so-called gabapentinoid (gabapentin, pregabalin).

Article Details

How to Cite
Sławek, J. (2018). Restless legs syndrome/Willis–Ekbom disease. Questions and answers. Medycyna Faktow (J EBM), 11(3(40), 238-244. https://doi.org/10.24292/01.MF.0318.12
Section
Articles

References

1. Garcia-Borreguero D., Silber M.H., Winkelman J.W.: Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016; 21: 1-11.
2. Tipton P.W., Wszołek Z.K.: Restless legs syndrome and nocturnal leg cramps: a review and guide to diagnosis and treatment. Pol. Arch. Intern. Med. 2017; 127(12): 865-872.
3. Winkelman J.W., Armstrong M.J., Allen R.P. et al.: Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2016; 87(24): 2585-2593.